Cite

HARVARD Citation

    Laurenti, R. et al. (2013). Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 Patients. Clinical & developmental immunology. p. . [Online]. 
  
Back to record